BioCentury | Dec 12, 2020
Regulation

CHMP’s December opinions include restrictions for Veklury in COVID, support for Daiichi, Seagen breast cancer drugs

...Technologies Corp. Bristol Myers Squibb Co. ViiV Healthcare Ltd. Celltrion Healthcare Co. Ltd. AbbVie Inc. Johnson & Johnson Merck KGaA Swedish Orphan Biovitrum AB bee2021 COVID-19 cov19count cov19count...
BioCentury | Nov 14, 2020
Regulation

BioMarin withdraws MAA for hemophilia gene therapy following safety, durability concerns

...its recommendation against approval for Gamifant emapalumab from Swedish Orphan Biovitrum AB...
...Inc. Stemline Therapeutics Inc. Samsung Bioepis Co. Ltd. Swedish Orphan Biovitrum AB Factor...
BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...Staff Apellis, Sobi enter territorial deal for C3 inhibitorApellis Pharmaceuticals Inc. (NASDAQ:APLS) granted Swedish Orphan Biovitrum AB...
...Altman and Jack Altman. TARGETSC3 – Complement 3TLR7 – Toll-like receptor 7 Paul Bonanos Apellis Pharmaceuticals Inc. Swedish Orphan Biovitrum AB Prokarium...
BioCentury | Oct 10, 2020
Product Development

Oct. 9 Quick Takes: Sobi’s Phase III miss; plus Alkermes, COVAX, Warp Speed-AZ, Lilly-Gates, Pfizer, Everest and Affamed-Kissei

...By BioCentury Staff Sobi’s avatrombopag misses in Phase III for chemotherapy-induced thrombocytopenia Swedish Orphan Biovitrum AB (SSE:SOBI) sank...
BioCentury | Aug 29, 2020
Management Tracks

Bi’s back; plus changes at Kymera, Immunovia, Apic, Vor, Organogenesis and more

...communications officer and Linea Aspesi as chief human resources officer. Both join from Swedish Orphan Biovitrum AB...
BioCentury | Aug 19, 2020
Management Tracks

Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more

...By Robin Sawka, BioCentury Staff Swedish Orphan Biovitrum AB (SSE:SOBI) said Ravi Rao will succeed Milan Zdravkovic...
...therapy company from Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), where he was EVP of technical operations. Robin Sawka Swedish Orphan Biovitrum AB Ikena...
BioCentury | Jul 24, 2020
Regulation

Data Bytes: CHMP’s July recommendations

...in BCMA Race” ). CHMP recommended against marketing authorization for Gamifant emapalumab from Swedish Orphan Biovitrum AB...
...ACP-196 (Compound #), acalabrutinib (Generic) bupivacaine/meloxicam (HTX-011) Imfinzi, durvalumab (MEDI4736) Shingrix (GSK1437173A, GSK137173A, hz/su, Herpes zoster vaccine) Swedish Orphan Biovitrum AB Stemline...
BioCentury | Jun 12, 2020
Product Development

June 11 Quick Takes: Sobi licenses Selecta gout therapy; plus Viela’s first approval, CSL, BMS, Sirnaomics’ spinout, Denali-Sanofi

...Sobi pays $100M up front for Selecta therapy Swedish Orphan Biovitrum AB (SSE:SOBI) licensed ex-China rights to...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...February. In response to a request from Italy’s National Institute for Infectious Diseases, Swedish Orphan Biovitrum AB...
...Interleukin-6 IFNγ - Interferon γ Sandi Wong, Assistant Editor Kineret, anakinra (Interleukin-1ra (IL-1ra)) Gamifant, emapalumab-lzsg (NI-0501) Swedish Orphan Biovitrum AB EUSA...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...He held the same position at Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB...
Items per page:
1 - 10 of 637
BioCentury | Dec 12, 2020
Regulation

CHMP’s December opinions include restrictions for Veklury in COVID, support for Daiichi, Seagen breast cancer drugs

...Technologies Corp. Bristol Myers Squibb Co. ViiV Healthcare Ltd. Celltrion Healthcare Co. Ltd. AbbVie Inc. Johnson & Johnson Merck KGaA Swedish Orphan Biovitrum AB bee2021 COVID-19 cov19count cov19count...
BioCentury | Nov 14, 2020
Regulation

BioMarin withdraws MAA for hemophilia gene therapy following safety, durability concerns

...its recommendation against approval for Gamifant emapalumab from Swedish Orphan Biovitrum AB...
...Inc. Stemline Therapeutics Inc. Samsung Bioepis Co. Ltd. Swedish Orphan Biovitrum AB Factor...
BioCentury | Oct 28, 2020
Finance

Oct. 27 Financial Quick Takes: Apellis-Sobi deal for C3 inhibitor; plus Primmune, Prokarium, Novartis-RegenxBio, Turning Point, Psyomics, Journey Colab

...Staff Apellis, Sobi enter territorial deal for C3 inhibitorApellis Pharmaceuticals Inc. (NASDAQ:APLS) granted Swedish Orphan Biovitrum AB...
...Altman and Jack Altman. TARGETSC3 – Complement 3TLR7 – Toll-like receptor 7 Paul Bonanos Apellis Pharmaceuticals Inc. Swedish Orphan Biovitrum AB Prokarium...
BioCentury | Oct 10, 2020
Product Development

Oct. 9 Quick Takes: Sobi’s Phase III miss; plus Alkermes, COVAX, Warp Speed-AZ, Lilly-Gates, Pfizer, Everest and Affamed-Kissei

...By BioCentury Staff Sobi’s avatrombopag misses in Phase III for chemotherapy-induced thrombocytopenia Swedish Orphan Biovitrum AB (SSE:SOBI) sank...
BioCentury | Aug 29, 2020
Management Tracks

Bi’s back; plus changes at Kymera, Immunovia, Apic, Vor, Organogenesis and more

...communications officer and Linea Aspesi as chief human resources officer. Both join from Swedish Orphan Biovitrum AB...
BioCentury | Aug 19, 2020
Management Tracks

Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more

...By Robin Sawka, BioCentury Staff Swedish Orphan Biovitrum AB (SSE:SOBI) said Ravi Rao will succeed Milan Zdravkovic...
...therapy company from Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), where he was EVP of technical operations. Robin Sawka Swedish Orphan Biovitrum AB Ikena...
BioCentury | Jul 24, 2020
Regulation

Data Bytes: CHMP’s July recommendations

...in BCMA Race” ). CHMP recommended against marketing authorization for Gamifant emapalumab from Swedish Orphan Biovitrum AB...
...ACP-196 (Compound #), acalabrutinib (Generic) bupivacaine/meloxicam (HTX-011) Imfinzi, durvalumab (MEDI4736) Shingrix (GSK1437173A, GSK137173A, hz/su, Herpes zoster vaccine) Swedish Orphan Biovitrum AB Stemline...
BioCentury | Jun 12, 2020
Product Development

June 11 Quick Takes: Sobi licenses Selecta gout therapy; plus Viela’s first approval, CSL, BMS, Sirnaomics’ spinout, Denali-Sanofi

...Sobi pays $100M up front for Selecta therapy Swedish Orphan Biovitrum AB (SSE:SOBI) licensed ex-China rights to...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...February. In response to a request from Italy’s National Institute for Infectious Diseases, Swedish Orphan Biovitrum AB...
...Interleukin-6 IFNγ - Interferon γ Sandi Wong, Assistant Editor Kineret, anakinra (Interleukin-1ra (IL-1ra)) Gamifant, emapalumab-lzsg (NI-0501) Swedish Orphan Biovitrum AB EUSA...
BioCentury | Jan 8, 2020
Company News

Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone

...He held the same position at Dova Pharmaceuticals Inc. until its acquisition by Swedish Orphan Biovitrum AB...
Items per page:
1 - 10 of 637